Schrodinger Inc (SDGR) Stock Price, Quote & News

Company Profile

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focu...

Industry: Health Information Services

Sector: Healthcare

Phone: 212 295 5800

Website: www.schrodinger.com

Address:

1540 Broadway, 24th Floor, New York, United States

bambus3001 Jun. 5 at 9:27 AM

$SDGR 1 Ziel mit 16 erreicht Weiter bis 24 -26 € In wenigen Monaten . Das Volumen immer zum ende stimmt mich sehr sehr Positiv!!!! Eine Plattform die noch viel von sich reden machen wird . Big Pharma sind alle sehr angetan und die Firma wär ein topp Buyout Kandidat

0 · Reply

bambus3001 Jun. 4 at 8:28 PM

$SDGR Und wieder zum schluss grosserr Tausch von Aktien , Riecht irgendwie nach einer großen Sache ,Buy out oder Topp News demnächst.

1 · Reply

OldTimer21 Jun. 4 at 2:51 PM

$SDGR Where has this little gem been hiding? I started a position here.

1 · Reply

PolycarpFX Jun. 3 at 6:22 PM

$SDGR

0 · Reply

bambus3001 Jun. 3 at 2:52 PM

$SDGR Bleibt stabil der Kurs , Ich werde weiter aufstocken ,auf diesen Niveau . Diese Perle mit der tollen Software hat fast eine Monopolstellung Big Pharma wird urgendwann eine feindliche Übernahme versuchen ,vermute Ich . 10MRD.€ Mk .mein Tipp.

0 · Reply

bambus3001 Jun. 2 at 8:28 PM

$SDGR Weiter Big player am kaufen , Karten werden neu sortiert Immer zum Börsenschluss noch hoher Umsatz.

0 · Reply

Weber10 Jun. 2 at 5:33 PM

$SDGR Ab sofort werde ich auf diesem Board nur noch Beiträge auf Deutsch verfassen, da ich glaube, dass dies die Aktie deutlich höher treiben wird.

0 · Reply

madnessofcrowds Jun. 2 at 4:38 PM

$SDGR bought some more

0 · Reply

Neubaufahrzeug Jun. 1 at 5:51 PM

$SDGR Unloading all for now.

4 · Reply

bambus3001 Jun. 1 at 2:05 PM

$SDGR 16 € war diese woche mein Ziel. 25 -27 in 3 Monaten 40 zum Jahresende meine Prognose . Wir werden noch positiv staunen lernen ,alle Big Player der Pharmabranche,wissen schon warum sie dort einsteigen .!!

1 · Reply

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

May 19, 2026, 2:05 PM EDT - 16 days ago

Schrödinger Transcript: RBC Capital Markets Global Healthcare Conference 2026

2026-05-14T16:24:26.000Z - 21 days ago

Schrodinger price target lowered to $17 from $19 at Morgan Stanley

May 13, 2026, 5:20 PM EDT - 22 days ago

Schrödinger Transcript: Bank of America Global Healthcare Conference 2026

May 5, 2026, 4:30 PM EDT - 4 weeks ago

Schrödinger Earnings Call Transcript: Q1 2026

May 5, 2026, 4:30 PM EDT - 4 weeks ago

Schrödinger Earnings release: Q1 2026

May 5, 2026, 4:30 PM EDT - 4 weeks ago

Schrödinger Quarterly report: Q1 2026

May 5, 2026, 4:30 PM EDT - 4 weeks ago

Schrödinger Slides: Q1 2026

May 5, 2026, 4:05 PM EDT - 4 weeks ago

Schrödinger Reports First Quarter 2026 Financial Results

May 4, 2026, 8:30 AM EDT - 4 weeks ago

Schrödinger to Participate in Upcoming Investor Conferences

Apr 28, 2026, 8:00 AM EDT - 5 weeks ago

Schrödinger Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 5 weeks ago

Schrödinger Proxy statement: Proxy filing

Apr 21, 2026, 8:30 AM EDT - 6 weeks ago

Schrödinger to Announce First Quarter 2026 Financial Results on May 5

2026-04-17T12:52:03.000Z - 6 weeks ago

Schrodinger reports inducement grants under Nasdaq listing rule

2026-04-13T10:44:45.000Z - 7 weeks ago

Schrodinger price target lowered to $20 from $25 at KeyBanc

Mar 17, 2026, 9:00 AM EDT - 2 months ago

Schrödinger Transcript: 2026 KeyBanc Capital Markets Healthcare Forum

2026-03-17T12:40:30.000Z - 2 months ago

Schrodinger price target lowered to $13 from $18 at UBS

Mar 10, 2026, 1:40 PM EDT - 3 months ago

Schrödinger Transcript: Leerink Global Healthcare Conference 2026

Mar 3, 2026, 9:50 AM EST - 3 months ago

Schrödinger Transcript: TD Cowen 46th Annual Health Care Conference

2026-02-26T14:49:36.000Z - 3 months ago

Schrodinger price target lowered to $20 from $24 at BofA

2026-02-25T21:49:18.000Z - 3 months ago

Schrodinger reports FY25 EPS ($1.41) vs. ($2.57) last year

Feb 25, 2026, 4:30 PM EST - 3 months ago

Schrödinger Earnings Call Transcript: Q4 2025

Feb 25, 2026, 4:30 PM EST - 3 months ago

Schrödinger Annual report: Q4 2025

Feb 25, 2026, 4:30 PM EST - 3 months ago

Schrödinger Earnings release: Q4 2025

Feb 25, 2026, 4:30 PM EST - 3 months ago

Schrödinger Slides: Q4 2025

Feb 25, 2026, 4:05 PM EST - 3 months ago

Schrödinger Reports Fourth Quarter and Full-Year 2025 Financial Results

Feb 11, 2026, 8:30 AM EST - 4 months ago

Schrödinger to Announce Fourth Quarter and Full-Year 2025 Financial Results on February 25

Jan 12, 2026, 8:30 AM EST - 5 months ago

Schrödinger Provides Update on Progress Across the Business and Outlines 2026 Strategic Priorities

2026-01-09T12:13:36.000Z - 5 months ago

Schrodinger announces collaboration with Lilly TuneLab

LLY

Jan 9, 2026, 7:04 AM EST - 5 months ago

Schrodinger to offer Eli Lilly's AI drug discovery platform on its software

LLY

Jan 9, 2026, 7:00 AM EST - 5 months ago

Schrödinger Partners with Lilly to Make TuneLab Platform Available in LiveDesign

2026-01-08T14:41:54.000Z - 5 months ago

Schrodinger price target lowered to $24 from $33 at TD Cowen

2026-01-08T12:47:13.000Z - 5 months ago

Schrodinger price target raised to $19 from $18 at Morgan Stanley

2026-01-08T12:46:07.000Z - 5 months ago

Schrodinger price target lowered to $25 from $28 at KeyBanc

2026-01-07T13:27:32.000Z - 5 months ago

Schrodinger initiated with a Neutral at UBS

2025-12-15T11:30:24.000Z - 6 months ago

BofA shakes up ratings in Biopharma Services with seven changes

AVTR CRL ICLR MTD RVTY ZTS

2025-12-15T11:25:26.000Z - 6 months ago

Schrodinger upgraded to Buy from Neutral at BofA

2025-12-15T11:16:32.000Z - 6 months ago

Schrodinger upgraded to Buy from Neutral at BofA

2025-12-12T01:25:11.000Z - 6 months ago

Cathie Wood’s ARK Investment buys 36.6K shares of Schrodinger today

Nov 19, 2025, 11:00 AM EST - 7 months ago

Schrödinger Transcript: Jefferies London Healthcare Conference 2025

Nov 6, 2025, 8:30 AM EST - 7 months ago

Schrödinger to Present at Jefferies London Healthcare Conference

Nov 5, 2025, 4:30 PM EST - 7 months ago

Schrödinger Earnings Call Transcript: Q3 2025

Nov 5, 2025, 4:30 PM EST - 7 months ago

Schrödinger Quarterly report: Q3 2025

Nov 5, 2025, 4:30 PM EST - 7 months ago

Schrödinger Earnings release: Q3 2025

Nov 5, 2025, 4:30 PM EST - 7 months ago

Schrödinger Slides: Q3 2025

Nov 5, 2025, 4:05 PM EST - 7 months ago

Schrödinger Reports Third Quarter 2025 Financial Results

Oct 30, 2025, 7:30 AM EDT - 7 months ago

Copernic Catalysts Announces Achievement of Ammonia Catalyst Milestone in Research Collaboration with Schrödinger

Oct 22, 2025, 8:30 AM EDT - 8 months ago

Schrödinger to Announce Third Quarter 2025 Financial Results on November 5

Sep 8, 2025, 11:30 AM EDT - 9 months ago

Schrödinger Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 27, 2025, 8:30 AM EDT - 10 months ago

Schrödinger to Present at Morgan Stanley Global Healthcare Conference

Aug 14, 2025, 7:00 AM EDT - 10 months ago

Schrödinger Announces Discontinuation of SGR-2921 Program

Aug 6, 2025, 4:30 PM EDT - 10 months ago

Schrödinger Earnings Call Transcript: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 10 months ago

Schrödinger Quarterly report: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 10 months ago

Schrödinger Earnings release: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 10 months ago

Schrödinger Slides: Q2 2025

Aug 6, 2025, 4:05 PM EDT - 10 months ago

Schrödinger Reports Second Quarter 2025 Financial Results

Jul 25, 2025, 8:30 AM EDT - 11 months ago

Schrödinger to Announce Second Quarter 2025 Financial Results on August 6

Jul 18, 2025, 10:25 AM EDT - 11 months ago

Material Informatics Company Evaluation Report 2025 | Schrodinger, Dassault Systèmes, and Citrine Informatics Drive Market Growth Through AI, Simulation, and Collaboration

Jul 17, 2025, 8:00 AM EDT - 11 months ago

Ajax Therapeutics and Schrödinger Expand Research Collaboration to Include Additional JAK Target

$Schrödinger Receives Fast Track Designation for SGR-1505 for the Treatment of Relapsed/Refractory Waldenström Macroglobulinemia$

Jun 27, 2025, 8:00 AM EDT - 1 year ago

Schrödinger Receives Fast Track Designation for SGR-1505 for the Treatment of Relapsed/Refractory Waldenström Macroglobulinemia

Jun 18, 2025, 12:00 PM EDT - 1 year ago

Schrödinger Transcript: AGM 2025

Jun 12, 2025, 8:00 AM EDT - 1 year ago

Schrödinger Transcript: Status Update

Jun 12, 2025, 8:00 AM EDT - 1 year ago

Schrödinger Press release: Status Update

Jun 12, 2025, 8:00 AM EDT - 1 year ago

Schrödinger Slides: Status Update

Jun 12, 2025, 7:00 AM EDT - 1 year ago

Schrödinger Reports Encouraging Initial Phase 1 Clinical Data for SGR-1505 at EHA Annual Congress

Jun 4, 2025, 1:25 PM EDT - 1 year ago

Schrödinger Transcript: Jefferies Global Healthcare Conference 2025

May 29, 2025, 5:00 PM EDT - 1 year ago

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Commercial Officer

May 29, 2025, 8:00 AM EDT - 1 year ago

Schrödinger Expands Executive Leadership Team with Appointment of Mannix Aklian as Chief Commercial Officer, Global Head of Software Sales and Marketing

May 28, 2025, 12:22 PM EDT - 1 year ago

Jefferies' Michael Yee: Drug discovery could be one of the biggest beneficiaries of generative AI

AMGN BIIB DHR GILD IBB ILMN NVS

May 22, 2025, 8:30 AM EDT - 1 year ago

Schrödinger to Present at Jefferies Global Healthcare Conference

May 20, 2025, 6:30 AM EDT - 1 year ago

Schrödinger Announces CFO Appointment

May 14, 2025, 4:40 PM EDT - 1 year ago

Schrödinger Transcript: BofA Securities 2025 Healthcare Conference

May 14, 2025, 9:30 AM EDT - 1 year ago

Schrödinger to Present Phase 1 Clinical Data on MALT1 Inhibitor SGR-1505 at EHA Annual Congress and International Conference on Malignant Lymphoma

May 7, 2025, 4:30 PM EDT - 1 year ago

Schrödinger Earnings Call Transcript: Q1 2025

May 7, 2025, 4:30 PM EDT - 1 year ago

Schrödinger Quarterly report: Q1 2025

May 7, 2025, 4:30 PM EDT - 1 year ago

Schrödinger Earnings release: Q1 2025

May 7, 2025, 4:30 PM EDT - 1 year ago

Schrödinger Slides: Q1 2025

May 7, 2025, 4:05 PM EDT - 1 year ago

Schrödinger Reports Strong First Quarter 2025 Financial Results

May 5, 2025, 8:30 AM EDT - 1 year ago

Schrödinger to Present at BofA Securities 2025 Healthcare Conference

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Schrödinger Presents New Preclinical Data at AACR Annual Meeting

Apr 24, 2025, 8:00 AM EDT - 1 year ago

Schrödinger Proxy statement: Proxy Filing

Apr 24, 2025, 8:00 AM EDT - 1 year ago

Schrödinger Proxy statement: Proxy Filing

Apr 23, 2025, 8:30 AM EDT - 1 year ago

Schrödinger to Announce First Quarter 2025 Financial Results on May 7

Apr 14, 2025, 8:00 AM EDT - 1 year ago

Schrödinger's Statement Regarding FDA Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs

Mar 18, 2025, 9:00 AM EDT - 1 year ago

Schrödinger Transcript: KeyBanc Annual Health Care Forum 2025

Mar 10, 2025, 3:40 PM EDT - 1 year ago

Schrödinger Transcript: Leerink Global Healthcare Conference 2025

Mar 10, 2025, 8:30 AM EDT - 1 year ago

Schrödinger Expands Board of Directors with Appointment of Bridget van Kralingen

bambus3001 Jun. 5 at 9:27 AM

0 · Reply

bambus3001 Jun. 4 at 8:28 PM

$SDGR Und wieder zum schluss grosserr Tausch von Aktien , Riecht irgendwie nach einer großen Sache ,Buy out oder Topp News demnächst.

1 · Reply

OldTimer21 Jun. 4 at 2:51 PM

$SDGR Where has this little gem been hiding? I started a position here.

1 · Reply

PolycarpFX Jun. 3 at 6:22 PM

$SDGR

0 · Reply

bambus3001 Jun. 3 at 2:52 PM

0 · Reply

bambus3001 Jun. 2 at 8:28 PM

$SDGR Weiter Big player am kaufen , Karten werden neu sortiert Immer zum Börsenschluss noch hoher Umsatz.

0 · Reply

Weber10 Jun. 2 at 5:33 PM

$SDGR Ab sofort werde ich auf diesem Board nur noch Beiträge auf Deutsch verfassen, da ich glaube, dass dies die Aktie deutlich höher treiben wird.

0 · Reply

madnessofcrowds Jun. 2 at 4:38 PM

$SDGR bought some more

0 · Reply

Neubaufahrzeug Jun. 1 at 5:51 PM

$SDGR Unloading all for now.

4 · Reply

bambus3001 Jun. 1 at 2:05 PM

1 · Reply

NGCS May. 29 at 11:27 PM

Why am I holding $TVGN for the long tech run? Look at AI drug discovery validation: 🔹 $RXRX: $12B Roche alliance + Nvidia backing. 🔹 $SDGR: Recurrent software revenue from top 20 big pharma. 🔹 Exscientia: Massively partnered w/ Bristol Myers Squibb & Sanofi. Big Pharma pays billions for predictive AI that cuts lab trial-and-error. Tevogen.AI with Microsoft cloud infrastructure is next in line. 💎🔥 IMO Big players are accumulating because the AI biotech space is a gold rush. The tech is real: - Recursion ($RXRX) merged with Exscientia to dominate chemistry+biology, validated by massive Sanofi/BMS/Roche partnerships. - Schrödinger ($SDGR) proved software cash-flow is stable. - Tevogen.AI's PredicTcell is built on the same disruptive tech demand. When the first licensing deal drops, this shorts-heavy stock explodes. 📈👀 NFA

1 · Reply

WallStJesus May. 29 at 5:35 PM

$SDGR SEP BULL BET THERE TODAY

0 · Reply

scott52 May. 28 at 8:22 PM

$SDGR Weird.

0 · Reply

bambus3001 May. 28 at 8:02 PM

$SDGR Na siehste zum schluss wieder big Player show down nenn Ich das. Kurse bis 20 klarer Kauf .

0 · Reply

gratefultobe May. 28 at 7:38 PM

$SDGR oh. No the German took over! Well I think we go to $20S soon

0 · Reply

bambus3001 May. 28 at 3:54 PM

$SDGR Hendrik Leber Von Acatis Fonds,handelt seit langen Zeiten wie Warren Buffet,Er war der Lehrer für ihn ,und diese Strategie ist wohl nicht zu verachten .😆😆😆👍👍👍

0 · Reply

bambus3001 May. 27 at 7:17 PM

$SDGR der nächste Sprung steht kurz bevor, Ich tippe 16 Dollar bis nächste Woche. 20% kurzfristig

1 · Reply

bambus3001 May. 26 at 9:52 PM

$SDGR After hour Wir werden weiter steigen. Zum schluss kaufen die Profis munter weiter zu super Kursen.

0 · Reply

analyst331 May. 26 at 12:33 AM

$SDGR baby brother $MDAI GOT APPROVED. COME HANG

0 · Reply

bambus3001 May. 22 at 9:16 PM

$SDGR Acatis Fondsmanager Hendrik Leber ist ein vollprofi und er empfiehlt SDGR auch als topp pick

0 · Reply

bambus3001 May. 22 at 9:07 PM

$SDGR Substack hatts mal grob angedeutet ,wo unsere Reise noch hingehen wird.In einigen Jahren haben wir 3 stellige Kurse ,riesen Potenzial steckt hier drin . Vergleichbar mit Hood und ihrer Plattform.

0 · Reply

InvestwithMEH May. 22 at 11:01 AM

$SDGR building its base, the longer the base the higher to space ✌️ https://jlgas2023.substack.com/p/sdgr-the-12-ai-drug-discovery-stock?r=1t0tw1

0 · Reply

Market Cap	1.10B
Revenue (ttm)	255.87M
Net Income (ttm)	-103.27M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-40.36%
Debt to Equity Ratio	0.00

Volume	2,498,100
Avg Vol	1,419,660
Day's Range	N/A - N/A
Shares Out	73.83M
Stochastic %K	82%
Beta	1.64
Analysts	Strong Sell
Price Target	$20.89